1- Anatomy (2 MCQs)

External Genitalia (Vulva)
  • Mons pubis: Fibro-fatty pad covering pubic ramus.
  • Labia majora: Contains sebaceous/sweat and apocrine glands. Deepest part connects to the inguinal canal and fibers of the round ligament.
  • Labia minora: No adipose tissue, contains sebaceous glands. Not well developed before puberty and atrophy post-menopause.
  • Clitoris: Erectile structure (0.5–3.5 cm) made of paired corpora cavernosa.
  • Vestibule: Cleft containing openings for urethra, vagina, and Bartholin's glands.
  • Bartholin’s glands: Bilateral (pea-sized). Open via a 2 cm duct below the hymen for lubrication.
The Vagina
  • Fibromuscular canal lined with stratified squamous epithelium. It has no glands (moistened by transudation and cervical mucus).
  • Length: Posterior wall is longer (9 cm) than the anterior wall (7 cm).
  • Epithelium is rich in glycogen. Doderlein’s bacillus (normal commensal) breaks glycogen into lactic acid, maintaining a protective acidic pH (around 4.5).
  • Relations: Upper posterior wall forms anterior reflection of Pouch of Douglas. Supported by cardinal and uterosacral ligaments.
The Uterus & Cervix
  • Uterus dimensions: 7.5 cm (L) x 5 cm (W) x 3 cm (T). Weighs ~70g.
  • Normal position: Anteversion (right angles to vagina) and Anteflexion (flexed at isthmus). Retroversion is normal in 20%, but fixed retroversion indicates endometriosis.
  • Cervix length: ~2.5 cm. The ureter runs ~1 cm laterally to the supravaginal cervix within the parametrium.
  • Endocervix: Columnar, ciliated epithelium secreting alkaline mucus. Meets squamous epithelium at the squamocolumnar junction.
Fallopian Tubes & Ovaries
  • Fallopian Tube (10 cm) Parts: Interstitial (intramural), Isthmus, Ampulla, Infundibulum. Runs in the mesosalpinx (upper margin of broad ligament).
  • Ovaries: Only intra-abdominal structure NOT covered by peritoneum. Attached to uterus via ovarian ligament, and to broad ligament via mesovarium.
  • Relations: Posterior to the ovary lies the ureter running down in front of the internal iliac artery.
Blood, Lymphatics & Nerves
  • Ovarian artery: Arises directly from the abdominal aorta (below renal artery), crosses ureter, enters infundibulopelvic fold.
  • Internal iliac artery (anterior division) supplies: Uterine, Vaginal, Vesical, Middle rectal, and Pudendal arteries. Uterine artery crosses the ureter.
  • Pelvic Diaphragm: Formed mainly by levator ani muscles (puborectalis, pubococcygeus, iliococcygeus). Nerve supply: S3, S4.
  • Pudendal nerve: Arises from S2, S3, S4. Divides into perineal nerve and dorsal nerve of clitoris.

💡 L1 Hints (High-Yield):

  • The vagina has NO glands; it is kept moist by transudation and cervical mucus.
  • Doderlein’s bacillus maintains vaginal pH at 4.5 by breaking down glycogen into lactic acid.
  • The ovary is the ONLY intra-abdominal organ not covered by peritoneum.
  • Surgical hazard: The ureter runs ~1 cm laterally to the supravaginal cervix within the parametrium.
  • The ovarian artery originates directly from the abdominal aorta, while the uterine artery is a branch of the internal iliac.

2- Physiology of Menstruation (2 MCQs)

Ovarian Cycle: Follicular Growth
  • Gonadotropin-independent phase: Primary oocytes arrested in prophase of 1st meiotic division. Takes ~74-80 days. Regulated by paracrine factors like Anti-Müllerian Hormone (AMH).
  • Primordial follicle pool: Peak at 20 weeks gestation (5-6 million) → Birth (1-2 million) → Puberty (400,000) → Menopause (<1000). Only ~500 ovulate.
  • Gonadotropin-dependent phase: Rescue of preantral follicles by Follicle-Stimulating Hormone (FSH).
  • Two-cell, Two-gonadotropin theory: Luteinizing Hormone (LH) acts on Theca cells to produce androgens. FSH acts on Granulosa cells to induce aromatase enzyme (converts androgens to estrogens).
Selection, Ovulation & Luteal Phase
  • Selection: Dominant follicle selected around day 7-8 due to rising estrogen and inhibin A causing negative feedback on FSH. Graafian follicle develops LH receptors.
  • Ovulation: Triggered by peak Estradiol (300-400 pg/ml) causing an LH surge. Ovulation occurs 34-39 hours after LH surge onset.
  • LH surge causes: Resumption of meiosis (extrusion of 1st polar body), prostaglandin synthesis, and follicular rupture.
  • Luteal Phase: Corpus luteum secretes Progesterone, Estrogen, Inhibin A. Fixed lifespan of 14 days. Rescued by Human Chorionic Gonadotropin (hCG) if pregnancy occurs.
Endometrial (Menstrual) Cycle
  • Proliferative phase: Estrogen-driven. Endometrial glands proliferate, thickness reaches 6-8 mm.
  • Secretory phase: Progesterone-driven. Stromal decidualization (spiral arteries coil, immune cells recruited). Peak receptivity 7-9 days post-ovulation (Implantation window).
  • Menstruation: Falling hormones cause apoptosis, prostaglandin release, vasoconstriction/ischemia, leading to sloughing (lasts 2-6 days, blood loss 20-80 ml).

💡 L2 Hints (High-Yield):

  • Primary oocytes are arrested in prophase of the 1st meiotic division.
  • The Luteal phase has a fixed lifespan of 14 days; cycle variation is due to the follicular phase.
  • LH surge is the direct trigger for ovulation, occurring exactly 34-39 hours prior to follicular rupture.
  • In the 2-cell theory, FSH induces aromatase in granulosa cells to convert theca-derived androgens to estrogens.
  • Peak endometrial receptivity for implantation is 7-9 days post-ovulation.

3- Puberty and its disorders (4 MCQs)

Normal Puberty & Tanner Stages
  • Onset: Ages 8-13. Initiated by pulsatile Gonadotropin-Releasing Hormone (GnRH) from the arcuate nucleus. Genetics has a dominant role, but race and nutrition play a part.
  • Leptin (released from adipose tissue) acts as a primary signal to the hypothalamus to commence puberty (higher BMI = earlier puberty).
  • Kisspeptin and other puberty-activating/inhibitor genes are deeply involved in puberty onset.
  • Order of changes: Thelarche (breast budding, first physical sign, 2-3 yrs before menarche) → Adrenarche/Pubarche (pubic hair) → Growth spurt → Menarche (mean age 12.8 yrs).
  • Tanner Stages:
    • Stage 1: No glandular breast tissue, no pubic hair.
    • Stage 2: Breast bud palpable under areola (first sign). Downy pubic hair.
    • Stage 3: Breast tissue outside areola. Scant terminal hair.
    • Stage 4: Areola elevated above breast contour ("double scoop"). Terminal hair fills the pubic triangle.
    • Stage 5: Areola recedes into single contour, papillae project. Hair extends to thighs.
  • Health risks: Early menarche increases risks for breast cancer, CVD, depression, and diabetes.
Precocious Puberty (Before age 8)
  • Definition: Onset of puberty before age 8 in girls.
  • Premature Adrenarche: Most common cause of referral. High DHEA. Associated with high BMI. Must exclude Late-onset Congenital Adrenal Hyperplasia (CAH) via 17-hydroxyprogesterone (17-OHP).
  • Premature Thelarche: Isolated early breast growth, usually very slow and benign.
  • Central Precocious Puberty: Early HPO axis activation. Mostly idiopathic (mutations in MKRN-3 gene may be found). 20% have CNS tumors if onset is < 6 years (Brain MRI indicated). Treat with GnRH analogues to prevent premature epiphyseal fusion (prevents short adult height). Withdrawn around age 11.
  • Peripheral Precocious Puberty: Estrogen/Androgen secreting tumors. Exclude McCune-Albright syndrome (polyostotic fibrous dysplasia, café-au-lait spots, ovarian cysts). Treat surgically if tumor.
Delayed Puberty (No secondary signs by 13.5 yrs)
  • Hypogonadotropic hypogonadism (Central): Low FSH/LH. Causes: Anorexia nervosa, excessive exercise, chronic illness (diabetes/renal failure), Kallmann syndrome, pituitary tumors.
  • Hypergonadotropic hypogonadism (Gonadal failure): High FSH/LH. Causes: Turner syndrome (45,X), XX gonadal dysgenesis, Premature Ovarian Failure (autoimmune, chemo/radiotherapy).
  • Approximately 50% of cases are constitutional delay (will catch up by age 18). Proof of normality is extremely important to reassure mothers.

💡 L3 Hints (High-Yield):

  • Thelarche (Tanner Stage 2) is the very first physical sign of female puberty.
  • Leptin from adipose tissue is a primary metabolic signal to the hypothalamus to start puberty.
  • 17-hydroxyprogesterone (17-OHP) is the specific diagnostic marker to rule out late-onset CAH in premature adrenarche.
  • In girls with central precocious puberty under age 6, rule out CNS tumors (20% risk) via brain MRI.
  • GnRH analogues are the standard treatment for central precocious puberty to prevent short adult height.

4- Pelvic Inflammatory Disease (5 MCQs)

Etiology & Pathophysiology
  • Polymicrobial ascending infection. Most frequent: Chlamydia trachomatis & Neisseria gonorrhoeae.
  • Risk Factors: Young age (<25 years), history of STI, lack of condom use, multiple partners, termination of pregnancy (TOP), insertion of IUD in the previous 6 weeks, HSG, IVF procedures, and Bacterial Vaginosis (BV). Vaginal douching does not *cause* PID directly, but is associated with it due to discharge.
  • Causes endometritis, salpingitis, tubo-ovarian abscesses. Leads to tubal scarring, increasing risk of ectopic pregnancy and infertility.
  • Fitz-Hugh-Curtis syndrome: Right upper quadrant pain due to perihepatitis ("violin string" adhesions between liver and peritoneum, 10-20% of cases).
  • Pelvic Actinomyces: Associated with long-term IUD use. Presents as a chronic pelvic mass. *Surgery should be avoided* due to risk of bowel damage.
Diagnosis & Differential Diagnosis
  • Symptoms: Lower abdominal pain, fever >38°C, dyspareunia, unscheduled/post-coital bleeding (due to cervicitis/endometritis). (Low diagnostic specificity 65-90%).
  • Differential Diagnosis (Must Exclude): Ectopic pregnancy, acute appendicitis, UTI, endometriosis, ovarian cyst torsion/rupture, constipation.
  • Mandatory Test: Urinary pregnancy test to exclude ectopic pregnancy.
  • Microbiology: Nucleic Acid Amplification Test (NAAT) for Chlamydia/Gonorrhea on a vulvo-vaginal swab. Testing for Mycoplasma genitalium is highly advisable.
  • Gram-stain Smear: A *lack of polymorphs* on a cervical smear has a high negative predictive value (makes PID unlikely).
  • Gold Standard: Laparoscopy (reserved for doubtful cases or failure of antibiotics after 48-72h).
Management
  • Clinicians must have a *low threshold* for treating empirically to prevent irreversible tubal damage.
  • Outpatient: Ofloxacin + Metronidazole (14 days), OR Ceftriaxone 500mg IM + Doxycycline + Metronidazole. *Avoid Ofloxacin/Moxifloxacin if Gonorrhea suspected due to high quinolone resistance.*
  • Inpatient Indications: Severe disease, pregnant, tubo-ovarian abscess, failure of oral therapy, immunodeficiency.
  • Inpatient Regimen: IV Ceftriaxone + Doxycycline OR IV Clindamycin + Gentamicin.
  • Husband must be screened and treated empirically (e.g., Azithromycin 1g). Abstain from intercourse.
  • IUD Management: Remove IUD if symptoms haven't resolved within 72 hours of starting antibiotics.

💡 L4 Hints (High-Yield):

  • Insertion of an IUD within the previous 6 weeks is a key iatrogenic risk factor for PID.
  • Lack of polymorphs on a Gram-stained cervical smear effectively rules out PID (high negative predictive value).
  • Fitz-Hugh-Curtis syndrome presents as RUQ pain due to perihepatic "violin string" adhesions.
  • A Urinary Pregnancy Test is absolutely mandatory to exclude ectopic pregnancy before empirical Rx.
  • Male partners MUST be treated empirically (e.g., Azithromycin 1g) to prevent recurrence.

5- Lower Genital Tract Infection (2 MCQs)

Vulvovaginal Candidiasis
  • Pathogen: Candida albicans (80-92%). Risk factors: Pregnancy, high-dose COCP, broad-spectrum antibiotics, diabetes.
  • Symptoms: Intense itching, white curdy (cottage-cheese) discharge, vulval erythema. Normal vaginal pH (< 4.5).
  • Diagnosis: Microscopy shows pseudohyphae and blastospores.
  • Treatment: Topical Azoles (Clotrimazole) or Oral Fluconazole (150mg single dose, contraindicated in pregnancy). Not an STI; partner treatment not required.
Trichomonas Vaginalis
  • Pathogen: Flagellate protozoan. Sexually Transmitted Infection (STI).
  • Symptoms: Foul-smelling, frothy yellowish-green discharge, dysuria.
  • Sign: Strawberry cervix (punctate hemorrhages).
  • Diagnosis: Wet mount (motile protozoa), Gold standard is NAAT.
  • Treatment: Systemic Metronidazole (2g single dose or 400mg BD). Partner MUST be treated.
Bacterial Vaginosis (BV)
  • Pathophysiology: Depletion of normal Lactobacilli, overgrowth of Gardnerella vaginalis and anaerobes. Elevated pH.
  • Symptoms: Homogeneous, greyish-white discharge with a 'fishy' malodor. No vaginitis (not inflammatory).
  • Diagnosis: Amsel Criteria (requires 3 of 4): 1) Clue cells (epithelial cells covered in bacteria) 2) Homogenous grey-white discharge. 3) Vaginal pH > 4.5. 4) Positive Whiff test (fishy odor with 10% KOH).
  • Complications: Second-trimester miscarriage, preterm labor, PPROM.
  • Treatment: Oral or vaginal Metronidazole or Clindamycin. Douching should be avoided. Not an STI.

💡 L5 Hints (High-Yield):

  • Candida has a normal vaginal pH (<4.5) and presents with curdy discharge and severe itching.
  • Oral Fluconazole (for Candida) is strictly contraindicated in pregnancy.
  • Strawberry cervix (punctate hemorrhages) is classic for Trichomonas Vaginalis.
  • Amsel Criteria for BV requires 3 of 4: Clue cells, pH >4.5, fishy odor (KOH), homogenous discharge.
  • Bacterial Vaginosis in pregnancy is linked to second-trimester miscarriage and preterm labor.

6- Genital Prolapse (4 MCQs)

Anatomy, Etiology & Risk Factors
  • Definition: Downward displacement of pelvic organs. Levator ani muscles (puborectalis, pubococcygeus, iliococcygeus) form a bowl supporting organs.
  • Etiology: Pregnancy/Childbirth (most significant, stretches pudendal nerve & levator muscles), Aging/Menopause (estrogen withdrawal decreases skin collagen and rectus fascia elasticity), chronically increased intra-abdominal pressure (Constipation, Chronic Cough, heavy lifting, obesity).
  • Previous Surgery: Burch colposuspension fixes anterior wall but predisposes to rectocele and enterocele. Vaginal vault prolapse occurs in ~0.5% after hysterectomy.
Types, Diagnosis & Differential Diagnosis
  • Cystocele: Anterior vaginal wall. May cause urinary frequency, incomplete emptying, or hydronephrosis in severe cases.
  • Rectocele: Posterior vaginal wall. Causes difficulty in defecation (needing manual digitations).
  • Enterocele: Apical/posterior defect containing bowel.
  • Procidentia: Complete uterine prolapse.
  • Differential Diagnosis: Vaginal cysts, pedunculated fibroid polyp, urethral diverticulum, chronic uterine inversion.
  • Evaluation: POP-Q is the standard grading system. Patients examined in dorsal lithotomy position with Valsalva or left lateral with a Sims' speculum. Standing exam is best for accurate descent assessment.
Management Options
  • Conservative: Pelvic floor physiotherapy (mild cases), Intravaginal devices (Ring/Shelf Pessaries). Ring pessaries are for mild/moderate cases. Shelf pessaries are used for severe cases or vault prolapse. Must be changed every 6 months (add topical estrogen to prevent ulceration).
  • Surgical: - Anterior colporrhaphy for cystocele. - Posterior colporrhaphy for rectocele. - Vaginal hysterectomy for uterovaginal prolapse. - Abdominal sacrocolpopexy or Sacrospinous ligament fixation for Vaginal Vault Prolapse. - LeFort Colpocleisis: Obliterative procedure (suturing anterior to posterior wall) for elderly/frail women not desiring sexual function (very low complication rate).

💡 L6 Hints (High-Yield):

  • Levator ani muscles are the primary muscular support preventing POP.
  • Burch colposuspension cures stress incontinence but leaves a defect predisposing to enterocele and rectocele.
  • Sims' speculum in the left lateral position is used to isolate and assess individual compartment defects.
  • Ring Pessaries are 1st line conservative Rx, must be changed every 6 months.
  • LeFort Colpocleisis is an obliterative surgery with very low complications, reserved for frail elderly women.

7- Polycystic Ovary Syndrome (2 MCQs)

Pathophysiology & Diagnosis
  • Most common endocrinopathy (8-15%). Characterized by Hypersecretion of Luteinizing Hormone (LH) and Insulin Resistance.
  • Insulin suppresses SHBG (Sex Hormone-Binding Globulin) increasing free testosterone, causing Hyperandrogenism.
  • Rotterdam Criteria (requires 2 of 3): 1) Ovulatory dysfunction (oligo/amenorrhea). 2) Clinical/Biochemical Hyperandrogenism (hirsutism, acne, alopecia). 3) Polycystic ovaries on ultrasound (≥12 follicles <10mm, increased stroma).
Consequences & Management
  • Health risks: Endometrial cancer (due to unopposed estrogen from chronic anovulation), Type 2 Diabetes Mellitus, Ischemic heart disease. Acanthosis nigricans is a sign of insulin resistance.
  • Obesity/Metabolic: First-line treatment is Weight Loss (improves ovulation and insulin resistance). Bariatric surgery if BMI > 35.
  • Menstrual Regulation: Combined Oral Contraceptive Pill (COCP) or intermittent Progestogens (Medroxyprogesterone) to prevent endometrial hyperplasia.
  • Hirsutism: Dianette (Cyproterone acetate + Ethinylestradiol) or Spironolactone. Topical Eflornithine. Cosmetic (Laser/Electrolysis). Takes 6-9 months for clinical effect.
  • Subfertility (Ovulation Induction): 1st line: Clomiphene citrate or Letrozole. 2nd line: Laparoscopic Ovarian Diathermy (drilling) or Gonadotropins. Risk of Ovarian Hyperstimulation Syndrome (OHSS) is high with gonadotropins.

💡 L7 Hints (High-Yield):

  • Diagnosis requires 2 out of 3 Rotterdam Criteria (Oligo/amenorrhea, Hyperandrogenism, PCO on US).
  • PCOS patients are at a significantly higher risk for Endometrial Cancer due to unopposed estrogen.
  • Weight loss is the single most important first-line intervention for obese PCOS patients.
  • Clomiphene citrate is the traditional first-line medical therapy for ovulation induction.
  • Ovarian Hyperstimulation Syndrome (OHSS) is a life-threatening risk of gonadotropin therapy.

8- Dysmenorrhea and Premenstrual Syndrome (2 MCQs)

Dysmenorrhea & Chronic Pelvic Pain
  • Primary Dysmenorrhea: Painful menstruation with NO pelvic pathology. Improves with age and childbirth. Prostaglandin mediated. Treatment: NSAIDs (Mefenamic acid), COCP, local Heat.
  • Secondary Dysmenorrhea: Pathological cause (Endometriosis, Adenomyosis, PID, Fibroids). Pain often precedes menstruation. Diagnosed via TVUSS or Diagnostic Laparoscopy (Gold standard for endometriosis). Treatment: Mirena (LNG-IUS), GnRH analogues, Surgery.
  • Chronic Pelvic Pain (CPP): Non-cyclical pain lasting > 6 months. Associated with somatic/psychological disorders. LUNA (Laparoscopic Uterosacral Nerve Ablation) is proven ineffective. Adhesiolysis may help.
Premenstrual Syndrome (PMS)
  • Cyclical somatic/psychological symptoms occurring strictly in the luteal phase and resolving with menstruation.
  • Caused by an abnormal central neurotransmitter (Serotonin) sensitivity to normal physiological Progesterone levels.
  • Diagnosis: Exclusively via prospectively completed symptom charts. GnRH analogue trial can confirm diagnosis by shutting down the ovarian cycle.
  • Management: - Non-medical: Exercise, Cognitive Behavioral Therapy (CBT). - Medical: Selective Serotonin Reuptake Inhibitors (SSRIs) like Fluoxetine (highly effective). - Ovarian suppression: Continuous COCP, Danazol (risk of masculinization), GnRH agonist analogues with add-back HRT (Tibolone). - Surgical: Bilateral oophorectomy with hysterectomy (last resort).

💡 L8 Hints (High-Yield):

  • Primary dysmenorrhea has no pelvic pathology and is treated first-line with NSAIDs or Heat.
  • Secondary dysmenorrhea pain often precedes bleeding; endometriosis is a key cause.
  • Chronic Pelvic Pain (CPP) is strictly defined as lasting more than 6 months.
  • PMS diagnosis requires prospectively completed symptom charts, NOT retrospective memory.
  • SSRIs (e.g., Fluoxetine) are the highly effective first-line medical treatment for severe PMS.

9- Subfertility (4 MCQs)

Definition & Epidemiology
  • Definition: Failure to conceive after 12 months of regular unprotected intercourse.
  • Epidemiology: Affects 9% of couples (70% primary, 30% secondary). Over 70 million couples worldwide.
  • Natural Conception Rates: 15-20% chance per cycle. Cumulative rates: 70% at 6 months, 80% at 12 months, 90% at 24 months.
  • Key Factors: Female age is the most critical factor (fertility falls sharply after 35). Male age also plays a role (semen quality drops >50 yrs). Intercourse frequency: 2-3 times per week is optimal.
  • External factors: Smoking, extremes of BMI, and stress decrease fertility. Folic acid 400 μg daily (or 5mg for high risk) and Vitamin D 10 μg daily are recommended.
Causes of Subfertility
  • In the UK: Male factor (30%), Female factor (30%), Unexplained (25%), Combined (15%).
  • Female Factors:
    • Ovulatory: PCOS (most common), hypothalamic hypogonadism, hyperprolactinemia, thyroid disease.
    • Tubal: PID, Endometriosis, Chlamydia (leading cause of hydrosalpinx), pelvic adhesions from previous surgery.
    • Uterine: Submucosal fibroids, endometrial polyps, Asherman syndrome (endometrial scarring).
  • Male Factors: Compromised sperm number/quality, orchitis, epididymal damage, iatrogenic (surgery/radiation), occupational hazards (chemicals), and genetic (Klinefelter XXY, AZF microdeletions).
  • Unexplained: Normal investigations but failure to conceive. May relate to undiagnosed oocyte/embryo quality issues.
Clinical Assessment & Investigations
  • Female Investigations:
    • Hormone Profile: Day 2-5 FSH, LH, and Oestradiol. AMH (Anti-Müllerian Hormone) is the most successful biochemical marker of ovarian reserve and is independent of the menstrual cycle.
    • Ovulation confirmation: Mid-luteal (Day 21) progesterone.
    • Imaging: TVUSS for pelvic anatomy, fibroids, and Antral Follicle Count (AFC) (AFC <4 predicts low response).
    • Tubal Assessment: HSG (using radioopaque dye and X-ray) or HyCoSy (using sono-opaque contrast and ultrasound). *Note: No test can effectively check tubal FUNCTION, only patency.*
  • Male Investigations:
    • Semen Fluid Analysis (SFA): Requires 2-4 days abstinence. WHO (2021) 5th centile lower limits: Volume 1.5 ml, Concentration 15 million/ml, Total number 39 million, Progressive motility 32%, Normal morphology 4%, Vitality 58%, pH > 7.2.
    • If abnormal, repeat in 3 months (allowing time for spermatogenesis).
Management Principles
  • Ovulation Induction: Clomiphene citrate (anti-estrogen) is 1st line; induces FSH release. 70% ovulate, 15-20% pregnancy per month. Risk of multiples (12%). Monitored by TVUSS. Alternatives: Letrozole, Gonadotropins, or Laparoscopic Ovarian Drilling for clomiphene-resistant PCOS.
  • Surgery: Laparoscopic ablation of endometriosis improves natural conception. Removal/disconnection of hydrosalpinges significantly improves IVF success. Hysteroscopic resection for submucosal fibroids, polyps, and Asherman's.
  • Unexplained Infertility: Expectant management (60% secondary infertility couples conceive in 3 years). IUI with COS (Controlled Ovarian Stimulation) for 2-3 cycles, followed by IVF as a last resort due to cost.

💡 L9 Hints (High-Yield):

  • The medical definition of subfertility requires 12 months of unprotected intercourse.
  • Female age is the single most important prognostic factor for fertility.
  • AMH (Anti-Müllerian Hormone) is the best biochemical marker for ovarian reserve as it is cycle-independent.
  • HSG tests for tubal *patency*, but currently, no test can effectively assess tubal *function*.
  • WHO 5th centile for sperm: Volume >1.5ml, Concentration >15 million/ml.

10- Assisted Reproductive Techniques (2 MCQs)

Core ART Protocols
  • Pre-requisites: Mandatory viral screening (HIV, Hep B/C). Female age dictates success rates (33% for <35 yrs, 5% for >43 yrs).
  • Intrauterine Insemination (IUI): Helpful for mild endometriosis or mild male factor. Often combined with Controlled Ovarian Stimulation (COS) using FSH and an hCG trigger.
  • IVF Steps:
    • 1. Pituitary Suppression: GnRH Agonists (cause initial "flare" then suppression over 10-14 days) or GnRH Antagonists (immediate block, no flare, reduces cycle duration).
    • 2. Superovulation: Recombinant FSH or hMG to achieve multifollicular development. Monitored strictly with TVUSS to prevent OHSS.
    • 3. Triggering: Final hCG injection administered 34–36 hours before oocyte retrieval.
    • 4. Retrieval & Fertilization: Transvaginal ultrasound-guided puncture. Standard IVF or ICSI (used specifically for severe male factor/azoospermia). Normal fertilization = 2 pronuclei.
    • 5. Embryo Transfer (ET): Transferred at cleavage (Day 2/3) or Blastocyst (Day 5/6) stage. Elective Single Embryo Transfer (eSET) is heavily recommended to prevent multiple pregnancies.
    • 6. Luteal Support: Exogenous progesterone is mandatory because pituitary was suppressed. Continued until 8-12 weeks when the placenta takes over.
Complications & Advanced Techniques
  • Ovarian Hyperstimulation Syndrome (OHSS): Affects 1-3%. Presents with ascites, enlarged ovaries, pulmonary edema, coagulopathy. Prevented by low-dose FSH, GnRH antagonists, and a "freeze-all" embryo policy.
  • Pre-implantation Genetic Testing (PGT): Biopsy at the blastocyst stage to screen for monogenic diseases (e.g., cystic fibrosis), translocations, or chromosomal aneuploidies before transferring the embryo.
  • Surgical Sperm Retrieval: Fine needle aspiration of epididymis/testis for patients with azoospermia. Sperm is then used for ICSI.

💡 L10 Hints (High-Yield):

  • The hCG trigger is administered exactly 34-36 hours prior to oocyte retrieval.
  • Normal fertilization is definitively confirmed by the presence of two pronuclei.
  • eSET (Elective Single Embryo Transfer) is heavily recommended to eliminate the high risks of multiple pregnancy.
  • OHSS (Ovarian Hyperstimulation Syndrome) is the most dangerous complication of IVF (1-3%).
  • ICSI is specifically mandatory when severe male factor infertility (e.g., severe oligospermia) is present.

11- Urogynecology (5 MCQs)

Types & Risk Factors
  • Urodynamic Stress Incontinence (USI): Involuntary leakage on exertion in the absence of a detrusor contraction. Due to urethral hypermobility or Intrinsic Sphincter Deficiency (ISD).
    Risk Factors: Vaginal childbirth, forceps delivery, birthweight >4kg, epidural analgesia, obesity, chronic cough, and alpha-adrenergic antagonists (relax sphincter).
  • Detrusor Overactivity (DO): Urodynamic diagnosis showing involuntary detrusor contractions during filling. Causes Overactive Bladder (OAB) symptoms.
    Risk Factors: Idiopathic (failure of bladder training), childhood bedwetting, prior hysterectomy, or previous continence surgery (5-10% risk of new DO). Neurogenic DO is seen in Multiple Sclerosis.
Investigations
  • Frequency-Volume Chart (Bladder Diary): 3-day record of fluid intake/output. Objective assessment of severity.
  • Pad Test: Objective measure of leakage volume. Only the 24-hour home pad test is reliable and reproducible.
  • Urodynamics: - Uroflowmetry: Normal peak flow ≥ 15 mL/s for 150 mL voided. - Subtracted Cystometry: Detrusor Pressure = Intravesical Pressure - Rectal Pressure. Normal capacity 400-600 mL.
  • Videocystourethrography: Combines cystometry, uroflowmetry, and radiological screening. Good for diverticula or fistulae.
  • Ultrasound: TVUSS measuring an empty bladder wall thickness >5 mm gives a 94% predictive value for DO.
  • Urethral Pressure Profilometry: Useful in failed incontinence surgeries to check maximum closure pressure.
Management of Stress Incontinence (USI)
  • Conservative: Pelvic Floor Muscle Training (Kegel), Weighted vaginal cones.
  • Medical: Duloxetine (SNRI, acts at the sacral spinal cord micturition center to increase sphincter tone). High nausea side effects.
  • Surgical: - Mid-urethral tapes (TVT/TOT): 80-85% success. Complications include voiding difficulty (2-5%) and bladder perforation (2-5%). - Burch Colposuspension: Suturing paravaginal fascia to pectineal ligament. - Urethral bulking agents for frail patients or failed cases.
Management of Detrusor Overactivity (OAB/DO)
  • Conservative: Bladder retraining/drill (increasing intervals between voids).
  • Medical: - Anticholinergics: Oxybutynin, Tolterodine, Solifenacin. Side effects: dry mouth, constipation, blurred vision. - Mirabegron: Beta-3 adrenergic agonist (enhances detrusor relaxation). - Desmopressin: Used for nocturia (Watch for hyponatremia).
  • Advanced/Surgical: - Intravesical Botulinum Toxin A (Botox): Paralyzes detrusor. 8-15% risk of voiding difficulty/retention requiring Clean Intermittent Self-Catheterization (CISC). - Sacral Neuromodulation. - Clam Cystoplasty (gut patch to expand bladder).
  • Mixed Incontinence: Treat DO first with antimuscarinic agents. If SUI persists after DO is controlled, proceed to continence surgery.

💡 L11 Hints (High-Yield):

  • USI (Urodynamic Stress Incontinence) is strictly defined by leakage in the *absence* of a detrusor contraction.
  • Subtracted Cystometry calculates true Detrusor Pressure by subtracting Rectal (abdominal) pressure from Vesical pressure.
  • Pelvic floor exercises are the first-line conservative management for both USI and DO.
  • Anticholinergics (e.g., Oxybutynin) are the gold standard medical therapy for Detrusor Overactivity (DO).
  • Mid-urethral tapes (TVT/TOT) are the highly successful (80-85%) surgical gold standard for USI.

Top 10 Comparisons (أهم 10 مقارنات)

1. HSG vs. HyCoSy (Tubal Assessment)
FeatureHysterosalpingography (HSG)Hysterocontrast Synography (HyCoSy)
Imaging ModalityX-rayUltrasound (including 3D)
Contrast MediumRadioopaque dyeSono-opaque contrast medium
MechanismDye instilled into uterus, flow captured by X-rays over timeContrast instilled, flow visualized dynamically on Ultrasound
Main UtilityAssesses tubal patency (not function)Assesses tubal patency (not function)
2. Gonadotropin-Independent vs. Gonadotropin-Dependent Phases
FeatureGonadotropin-IndependentGonadotropin-Dependent
Main RegulatorParacrine factors (e.g., AMH)Pituitary FSH and LH
Follicle StagePrimordial → Primary → SecondarySecondary (Preantral) → Graafian
Duration~74-80 Days~14 Days (Follicular phase of cycle)
Atresia RiskContinuous atresia regardless of hormonesRescued from atresia by rising FSH
3. Central vs. Peripheral Precocious Puberty
FeatureCentral Precocious PubertyPeripheral Precocious Puberty
PathophysiologyEarly activation of HPO axis (GnRH dependent)Sex steroid excess independent of HPO axis
Common CausesIdiopathic, CNS tumors (20% if <6 yrs)Ovarian/Adrenal tumors, McCune-Albright
TreatmentGnRH analoguesSurgical removal of tumor, treat underlying cause
4. Hypogonadotropic vs. Hypergonadotropic Hypogonadism
FeatureHypogonadotropic (Central)Hypergonadotropic (Gonadal)
Defect LocationHypothalamus/PituitaryOvaries (Gonadal Failure)
FSH / LH LevelsLowHigh
Common CausesAnorexia, excessive exercise, Kallmann syndromeTurner syndrome (45,X), Premature Ovarian Failure
5. Candida vs. Trichomonas vs. Bacterial Vaginosis
FeatureCandida AlbicansTrichomonas VaginalisBacterial Vaginosis (BV)
DischargeWhite, curdy (cottage-cheese)Yellow-green, frothy, foulGrey-white, fishy odor
Vaginal pHNormal (< 4.5)Elevated (> 4.5)Elevated (> 4.5)
DiagnosisPseudohyphae & blastosporesMotile flagellates, Strawberry cervixClue cells, Whiff test
TreatmentTopical Clotrimazole / Oral FluconazoleMetronidazoleMetronidazole / Clindamycin
Husband TreatmentNot required (not an STI)MUST be treated simultaneouslyNot currently recommended
6. Primary vs. Secondary Dysmenorrhea
FeaturePrimary DysmenorrheaSecondary Dysmenorrhea
PathologyNo pelvic pathology (Prostaglandin mediated)Underlying pathology present
OnsetSince menarcheDevelops later in life
Pain TimingOccurs only with bleedingPain often precedes the period
Common CausesIdiopathicEndometriosis, Adenomyosis, Fibroids, PID
1st Line RxNSAIDs, HeatTreat underlying cause, Mirena (LNG-IUS)
7. Urodynamic Stress Incontinence (USI) vs. Detrusor Overactivity (DO)
FeatureUSIDO (Overactive Bladder)
PathophysiologyUrethral hypermobility or sphincter deficiencyInvoluntary detrusor contractions during filling
SymptomsLeakage on coughing/sneezing/exertionUrgency, frequency, nocturia, urge leakage
UrodynamicsLeakage without detrusor contractionDetrusor pressure rises during filling
Medical RxDuloxetine (acts on sacral cord)Anticholinergics (Oxybutynin), Mirabegron
Surgical RxMid-urethral tapes, ColposuspensionIntravesical Botox, Sacral neuromodulation
8. GnRH Agonists vs. GnRH Antagonists in IVF
FeatureGnRH AgonistsGnRH Antagonists
MechanismReceptor interaction causing initial flare, then suppressionImmediate blockage of GnRH receptors
Initial EffectFlare effect (initial surge in FSH/LH)No flare effect
Time to Suppress10-14 daysImmediate
Side EffectsHypo-estrogenic (hot flushes, headaches)Mild anaphylactic reactions (histamine release)
9. Clomiphene Citrate vs. Laparoscopic Ovarian Diathermy (PCOS)
FeatureClomiphene CitrateLaparoscopic Ovarian Diathermy
TypeMedical (Oral anti-estrogen)Surgical (Minimal access)
Indication1st line for ovulation induction2nd line (for Clomiphene-resistant PCOS)
Risk of MultiplesIncreased (~12%)Free of multiple pregnancy risk
Risk of OHSSPresent (requires ultrasound tracking)Free of OHSS risk
10. Anterior Colporrhaphy vs. Mid-urethral Tapes
FeatureAnterior ColporrhaphyMid-Urethral Tapes (TVT/TOT)
Primary IndicationCystocele (Anterior compartment prolapse)Urodynamic Stress Incontinence (USI)
USI Cure RatePoor compared to suprapubic proceduresExcellent (80-85%)
Material UsedPatient's native tissue (fascia plication)Non-absorbable polypropylene mesh
ComplicationsRecurrence of prolapseMesh erosion, voiding difficulty, bladder perforation